In order to determine how UCA1 activates the PI3K/AKT pathway in cisplatin resistance of GC, we specifically knockdown EZH2 in MKN45/UCA1 and MGC803/UCA1 cells. This evidence concerns the gene EZH2 and gastric cancer.